Santa Cruz, CA – According to filings with the U.S. Securities and Exchange Commission, Emboline is raising $60,067,800.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Scott Russell played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Emboline

Emboline is a medical technology company based in Santa Cruz, CA, USA with a game-changing device for total embolic protection during percutaneous heart valve repair and replacement procedures and other cardiovascular procedures with embolic risks. Emboline’s technologies are derived from intellectual property invented by Amir Belson, MD. Interventional heart procedures such as transcatheter aortic valve replacement (TAVR) have revolutionized cardiology, providing lower-risk alternatives to open-heart surgery. However, these procedures are performed on a beating heart and can cause a shower of embolic debris to be released into the bloodstream. The Emboliner Total Embolic Protection Catheter is the only embolic protection device designed to provide complete protection of the brain and other critical organs by capturing and removing emboli produced during the procedure.

To learn more about Emboline, visit http://emboline.com/

Contact:
Scott Russell, President and Chief Executive Officer
831-900-5020
https://www.linkedin.com/in/scottrussell-emboline/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved